Vaccine Research

Government officials have scrapped plans for a major human trial of a new HIV vaccine, still convinced that there is considerable basic research work that needs to be done before going back into the clinic after the disastrous failure last year of a key Merck trial. Report [1]

Emergent BioSolutions and Oxford University are teaming up to study a new TB vaccine. Story [2]

Researchers from Maryland and South Carolina have developed a novel four-component vaccine that protects monkeys against all four strains of dengue virus and may potentially offer protection to the millions of humans at risk worldwide. Release [3]

GeoVax Labs and France's Vivalis have agreed to link an experimental HIV vaccine with Vivalis' manufacturing technology. Report [4]

AlphaVax announced today the initiation of a Chlamydia vaccine program based on its alphavirus vector platform technology. Release [5]

Vaccine Market

Officials in Australia say that the new cervical cancer vaccine is so effective they expect to see deaths from the disease halved within two years. Story [6]

UK officials, meanwhile, say they will extend the government's HPV vaccination campaign to 300,000 more girls. Report [7]

After reviewing thousands of cases of adverse events related to Gardasil, FDA officials have confirmed that the drug is safe and effective. Report [8]

An increase of nine percent in Prevnar sales helped Wyeth boost its quarterly revenue figures. Story [9]